English
简体中文
Total: £ 56.28
2026-03-12 | Pages: 119 | Tables: 118
The global Irbesartan Amlodipine Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-03-12 | Pages: 119 | Tables: 124
The global Aceclofenac Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-12 | Pages: 109 | Tables: 109
The global Injectable Botulinum Toxin Type A market was valued at US$ 9020 million in 2025 and is anticipated to reach US$ 15570 million by 2032, at a CAGR of 8.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into th...
2026-03-12 | Pages: 105 | Tables: 110
The global Ezetimibe/Simvastatin Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Ezetimibe/Simvastatin Tablets is projected to increase fr...
2026-03-12 | Pages: 110 | Tables: 116
The global Peptide Vaccine for Tumor market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
2026-03-12 | Pages: 108 | Tables: 112
The global Polypeptide Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-12 | Pages: 91 | Tables: 95
The global Danshen Oral Liquid market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-12 | Pages: 117 | Tables: 116
The global Juhong Granules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This...
2026-03-12 | Pages: 106 | Tables: 101
The global Mizoribine Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. T...
2026-03-12 | Pages: 105 | Tables: 108
The global Oxycodone Hydrochloride Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Oxycodone Hydrochloride Capsules is projected to incre...
2026-03-12 | Pages: 110 | Tables: 109
The global Fexofenadine Hydrochloride Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-03-12 | Pages: 113 | Tables: 114
The global Benidipine Hydrochloride Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-03-12 | Pages: 110 | Tables: 108
The global Glucosamine Hydrochloride Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-03-12 | Pages: 120 | Tables: 123
The global Catecholamines Anorexiant Drug market was valued at US$ 791 million in 2025 and is anticipated to reach US$ 1115 million by 2032, at a CAGR of 5.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glo...
2026-03-12 | Pages: 119 | Tables: 119
The global Oral Anorexiant Drug market was valued at US$ 826 million in 2025 and is anticipated to reach US$ 1235 million by 2032, at a CAGR of 6.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econom...
